Biocon Biologics Denies Bribery Charge, Says Followed Regulations
Press Trust of India | Tuesday June 21, 2022, New DelhiBiocon Biologics has denied allegations of bribery against the company and its officials regarding approval for one of its products in India
Pharmacy Rules Soon To Regulate Online Portals: Government
Reported by Animesh Singh | Monday June 20, 2022Government may soon finalise e-pharmacy rules which would regulate online platforms selling medicines and issuing medication
Sun Pharma Records Rs 2,277 Crore March Quarter Net Loss
Press Trust of India | Monday May 30, 2022, New DelhiSun Pharmaceutical Industries on Monday said its consolidated net loss stood at Rs 2,277 crore for the fourth quarter ended March 2022
Healthcare Platform HealthUno Targets 25% Share in Online Doctor Consultation Space by 2025
Press Trust of India | Tuesday March 15, 2022, ChennaiThe Chennai-based healthcare consultation platform, HealthUno trains its eyes on a 25 per cent market share in India by 2025.
Dr Reddy's Plans 'Business Continuity' In Russia
Wednesday March 09, 2022, New DelhiIndian pharmaceutical major Dr. Reddy's Laboratories Ltd said on Wednesday it was focused on employee safety and business continuity in and around Russia, despite many Western companies pulling out from Russia in recent days.
Pharma Industry To Grow By 9% To 11% In 2021-22: ICRA
Edited by Animesh Singh | Tuesday January 04, 2022, New DelhiICRA has said that the pharmaceutical industry is estimated to grow at the rate of 9 per cent to 11 per cent in 2021-22 due to emerging markets
Lupin Receives Inspection Report From USFDA For Goa Manufacturing Facility
Press Trust of India | Tuesday December 14, 2021, New DelhiThe USFDA has determined that the inspection classification of the facility is VAI, the company said in a statement.
Government Notifies Facilities in Pune And Hyderabad For Covid Vaccine Testing
Edited by Animesh Singh | Sunday July 04, 2021To ramp up testing and quality control of Coronavirus vaccines, the Centre has notified two testing facilities in Pune and Hyderabad for the purpose.
Zydus Cadila Applies For Emergency Use Nod For Covid-19 Vaccine
Reuters | Thursday July 01, 2021An approval for Zydus' vaccine, ZyCoV-D, would make it the fifth vaccine authorized for use in the country.
From May 1, Pay More For Second Jab Of Covishield
Reported by Animesh Singh | Wednesday April 21, 2021COVID-19 vaccine: From May 1, 2021, a jab of Serum Institute of India's Covishield vaccine will cost Rs 600 in private hospitals.
India's New Unicorn Is EPharmacy
Saritha Rai, Bloomberg | Wednesday April 07, 2021API Holdings Pvt said it will use funds to expand its network and add more tele-consultations to link up customers with the 60,000 brick-and-mortar pharmacies and 4,000 doctors it already has on its books.
Cadila Seeks Nod To Repurpose Hepatitis C Drug For COVID-19 In India
Reuters | Monday April 05, 2021A single dose of the Hepatitis C drug when taken early could help COVID-19 patients recover faster and avoid complications seen in the advanced stages of the disease, Cadila said.
Indian Pharma Firms Go Local Seeking To End Reliance On China
Reuters | Tuesday February 23, 2021Indian Pharma Firms: Although India is known as the pharmacy of the world for its massive production capacities of both generic drugs and vaccines, China accounted for half of its API needs in 2019 from nearly nothing three decades ago
Dr Reddy's Starts Process For Emergency Use Authorisation Of Covid-19 Vaccine Sputnik V
Edited by Nirmalya Sen | Friday February 19, 2021Dr Reddy's will present the safety profile of phase two study and interim data of phase three study which is expected to completed by February 21
AstraZeneca Shares Up 4% On WHO's Emergency Use Approval Of Covid-19 Vaccine
Edited by Nirmalya Sen | Tuesday February 16, 2021WHO's move widens access to the relatively inexpensive shot in the developing world
